+151.8%
MRNA vs IP
-8.6%
+160.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | IP | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +2.2% | -4.4% | -3.7% |
| 7D | +5.5% | -5.3% | +10.7% | +9.1% |
| 30D | +158.7% | -10.9% | +169.6% | +178.8% |
| 3M | +182.1% | +11.2% | +171.0% | +184.2% |
| 6M | +151.8% | -10.2% | +162.0% | +170.4% |
| All | +151.8% | -8.6% | +160.4% | +170.4% |
Cumulative growth
Daily Returns
Daily percentage return beside IP.
Daily Out/Under-Performance
Portfolio return minus IP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded IP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling